QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 14, Issue 7, 2861-2875, July 2003

This Article Full Text Full Text (PDF) All Versions of this Article: E02-08-0544v1 14/7/2861    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bruneau, N. Articles by Lombardo, D. Search for Related Content PubMed PubMed Citation Articles by Bruneau, N. Articles by Lombardo, D.

Lectin-like Ox-LDL Receptor Is Expressed in Human INT-407 Intestinal Cells: Involvement in the Transcytosis of Pancreatic Bile Salt–dependent Lipase

INSERM U-559, Unité de Recherche de Physiopathologie des Cellules Epithéliales and Équipe d'Accueil 3289, Université de la Méditerranée, Faculté de Médecine, Marseilles, France

Submitted August 29, 2002; Revised March 13, 2003; Monitoring Editor: Keith Mostov

We have recently shown that the pancreatic bile salt–dependent lipase (BSDL) can be taken up by intestinal cells and transported to the blood circulation. This mechanism likely involves (specific) receptor(s) able to bind BSDL and located at the apical intestinal cell membrane. In this study, using Int407 human intestinal cells cultured to form a tight epithelium, we attempted to characterize (the) BSDL receptor(s). We found that an apical 50-kDa protein was able to bind BSDL. Further, we have demonstrated that Int407 cells expressed the lectin-like oxidized-LDL receptor (LOX-1), the upregulation of which by oxidized-LDL potentiates the transcytosis of BSDL, whereas carrageenan and to a lesser extent polyinosinic acid and fucoidan decrease the enzyme transcytosis. The mAb JTX92, which blocks the LOX-1 receptor function, also impaired the BSDL transcytosis. To confirm these results, the cDNA encoding the human intestinal receptor LOX-1 has been cloned, inserted into vectors, and transfected into Int407 cells. Overexpression of LOX-1 by these cells leads to a substantial increase in the BSDL transcytosis. Globally, these data support the view that LOX-1 could be an intestinal receptor for BSDL, which is implicated in the transcytosis of this enzyme throughout Int407 cells.

^* Corresponding author. E-mail address: nadine.bruneau{at}medecine.univ-mrs.fr.

This article has been cited by other articles:

				J. H. Dominguez, J. L. Mehta, D. Li, P. Wu, K. J. Kelly, C. S. Packer, C. Temm, E. Goss, L. Cheng, S. Zhang, et al. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations Am J Physiol Renal Physiol, January 1, 2008; 294(1): F110 - F119. [Abstract] [Full Text] [PDF]

				M. Cloutier, D. Gingras, and M. Bendayan Internalization and Transcytosis of Pancreatic Enzymes by the Intestinal Mucosa J. Histochem. Cytochem., July 1, 2006; 54(7): 781 - 794. [Abstract] [Full Text] [PDF]

				O. Rebai, J. Le Petit-Thevenin, N. Bruneau, D. Lombardo, and A. Verine In Vitro Angiogenic Effects of Pancreatic Bile Salt-Dependent Lipase Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 359 - 364. [Abstract] [Full Text] [PDF]